| Literature DB >> 34666312 |
Jennifer M Weiss1, Samir Gupta2, Carol A Burke3, Lisen Axell4, Lee-May Chen5, Daniel C Chung6, Katherine M Clayback7, Susan Dallas8, Seth Felder9, Olumide Gbolahan10, Francis M Giardiello11, William Grady12, Michael J Hall13, Heather Hampel14, Rachel Hodan15, Gregory Idos16, Priyanka Kanth17, Bryson Katona18, Laura Lamps19, Xavier Llor20, Patrick M Lynch21, Arnold J Markowitz22, Sara Pirzadeh-Miller23, Niloy Jewel Samadder24, David Shibata25, Benjamin J Swanson26, Brittany M Szymaniak27, Georgia L Wiesner28, Andrew Wolf29, Matthew B Yurgelun30, Mae Zakhour31, Susan D Darlow32, Mary A Dwyer32, Mallory Campbell32.
Abstract
Identifying individuals with hereditary syndromes allows for timely cancer surveillance, opportunities for risk reduction, and syndrome-specific management. Establishing criteria for hereditary cancer risk assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provides recommendations for the assessment and management of patients at risk for or diagnosed with high-risk colorectal cancer syndromes. The NCCN Genetic/Familial High-Risk Assessment: Colorectal panel meets annually to evaluate and update their recommendations based on their clinical expertise and new scientific data. These NCCN Guidelines Insights focus on familial adenomatous polyposis (FAP)/attenuated familial adenomatous polyposis (AFAP) syndrome and considerations for management of duodenal neoplasia.Entities:
Mesh：
Year: 2021 PMID： 34666312 DOI： 10.1164/jnccn.2021.0048
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908